RecruitingPhase 3NCT07377032
TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders
Studying GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Meyer Children's Hospital IRCCS
- Intervention
- L-serine(dietary_supplement)
- Enrollment
- 40 enrolled
- Eligibility
- 2-30 years · All sexes
- Timeline
- 2025 – 2028
Study locations (3)
- Hospices Civils de Lyon, Lyon, France
- Meyer Children's Hospital, Florence, Italy
- Children's Memorial Health Institute, Warsaw, Poland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07377032 on ClinicalTrials.gov